Elevated CO2 and Tree Species Affect Microbial Activity and Associated Aggregate Stability in Soil Amended with Litter

(1) Elevated atmospheric CO2 (eCO2) may affect organic inputs to woodland soils with potential consequences for C dynamics and associated aggregation; (2) The Bangor Free Air Concentration Enrichment experiment compared ambient (330 ppmv) and elevated (550 ppmv) CO2 regimes over four growing seasons (2005–2008) under Alnus glutinosa, Betula pendula and Fagus sylvatica. Litter from the experiment (autumn 2008) and Lumbricus terrestris were added to mesocosm soils. Microbial properties and aggregate stability were investigated in soil and earthworm casts. Soils taken from the field experiment in spring 2009 were also investigated; (3) eCO2 litter had lower N and higher C:N ratios. F. sylvatica and B. pendula litter had lower N and P than A. glutinosa; F. sylvatica had higher cellulose. In mesocosms, eCO2 litter decreased respiration, mineralization constant (respired C:total organic C) and soluble carbon in soil but not earthworm casts; microbial‐C and fungal hyphal length differed by species (A. glutinosa = B. pendula > F. sylvatica) not CO2 regime. eCO2 increased respiration in field aggregates but increased stability only under F. sylvatica; (4) Lower litter quality under eCO2 may restrict its initial decomposition, affecting C stabilization in aggregates. Later resistant materials may support microbial activity and increase aggregate stability. In woodland, C and soil aggregation dynamics may alter under eCO2, but outcomes may be influenced by tree species and earthworm activity

Effect of Plumage Colour on The Productive and Physiological Performance of Two Lines of Turkey During Egg Production Period

Using 32 hens from two turkey lines; broad-breasted bronze (BBB) and bourbon red (BR), this study assessed how plumage colour affects egg production and physiological functions during (26-40) weeks of observation. A total of 32 hens, namely 16 hens from the BBB line and 16 hens from the BR line, were bred from 26 weeks up to 40 weeks of age. According to our results, BBB line significantly (p≤0.05) outperformed BR line in terms of body weight at first egg production, feed intake, and yolk diameter during the study period. A significantly (p≤0.05) higher feed conversion ratio, an increased egg mass, a higher production rate of hen-day eggs, and a higher rate of albumen was achieved by the BR line. It is, however, noteworthy that the age at first egg production, the egg weight, the egg mass, the yolk weight, the yolk percentage, the albumen weight, the shell weight percentage, the egg shell thickness, width, and length, the shape index, yolk height and yolk index were not significantly (p≥0.05) different between the two lines at 24 and 36 weeks of age. The levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were not significantly (p≥0.05) different between the two lines at 24 and 36 weeks of age when eggs were produced. Both turkey lines presented in the current study can potentially be raised in Iraq, as well as used as hens to produce hatching eggs and for genetic improvement

Midtrimester preterm prelabour rupture of membranes (PPROM):expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial)

BACKGROUND: Babies born after midtrimester preterm prelabour rupture of membranes (PPROM) are at risk to develop neonatal pulmonary hypoplasia. Perinatal mortality and morbidity after this complication is high. Oligohydramnios in the midtrimester following PPROM is considered to cause a delay in lung development. Repeated transabdominal amnioinfusion with the objective to alleviate oligohydramnios might prevent this complication and might improve neonatal outcome. METHODS/DESIGN: Women with PPROM and persisting oligohydramnios between 16 and 24 weeks gestational age will be asked to participate in a multi-centre randomised controlled trial. Intervention: random allocation to (repeated) abdominal amnioinfusion (intervention) or expectant management (control). The primary outcome is perinatal mortality. Secondary outcomes are lethal pulmonary hypoplasia, non-lethal pulmonary hypoplasia, survival till discharge from NICU, neonatal mortality, chronic lung disease (CLD), number of days ventilatory support, necrotizing enterocolitis (NEC), periventricular leucomalacia (PVL) more than grade I, severe intraventricular hemorrhage (IVH) more than grade II, proven neonatal sepsis, gestational age at delivery, time to delivery, indication for delivery, successful amnioinfusion, placental abruption, cord prolapse, chorioamnionitis, fetal trauma due to puncture. The study will be evaluated according to intention to treat. To show a decrease in perinatal mortality from 70% to 35%, we need to randomise two groups of 28 women (two sided test, β-error 0.2 and α-error 0.05). DISCUSSION: This study will answer the question if (repeated) abdominal amnioinfusion after midtrimester PPROM with associated oligohydramnios improves perinatal survival and prevents pulmonary hypoplasia and other neonatal morbidities. Moreover, it will assess the risks associated with this procedure. TRIAL REGISTRATION: NTR3492 Dutch Trial Register (http://www.trialregister.nl)

Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?

The US Food and Drug Administration (FDA) is encouraging the innovation of long-acting opioid formulations that are manipulation-resistant. The purpose of this commentary is to assess the benefits and limitations of abuse-deterrent opioid formulations (ADFs) and discuss their role in mitigating the current opioid epidemic. ADFs have been created with chemical properties that make it difficult for people who non-medically use prescription drugs to crush and dissolve opioid tablets, as well as by combining opioids with antagonists such as naloxone or naltrexone, which are released only when the dosage form has been manipulated or the drug is taken by a non-intended route. Despite these and other technologies, consensus regarding the effectiveness of these formulations in preventing non-medical use is lacking given the difficulty in obtaining post-marketing data. Researchers also question if the creation of abuse-deterrent drugs will have a positive effect on those struggling with a severe opioid-use disorder, fearing that current opioid users will simply find a new – perhaps more dangerous – drug of choice. Abuse-deterrent opioids are still opioids, and although they may make manipulation more difficult than non-ADF formulations, they are not “abuse proof.” The introduction of ADFs could provide a false sense of security among prescribers and dispensers, and we fear that ADFs may have a minimal impact on non-medical use of prescription opioids. Further epidemiological studies will be required to determine the large-scale impact of abuse-deterrent opioids in preventing opioid use disorder and its downstream consequences

Performance quality of single and ?two stage solar concentrators

The performance of single and two stage solar concentrator were studied ' " The ratio of the primary to the secondary mirrors diameter is taking to be 0.5, depending on the theoretical calculation for the accumulated energy by the concentrator with ratio between 0.0 to 0.9. The design of the systems were designed and examined by using a ray-tracing program. The efficiency of the single and the two stage concentrators are calculated and compared with and without cooling systems